| Rank | Ticker | Country | Price | Revenue | Analyst Rating | Analysts | IPO Year |
|---|---|---|---|---|---|---|---|
#1 | SGHC | Guernsey | $10.81 | $2,342,912,011.00 | Strong Buy | 8 | N/A |
#2 | GLW | United States | $84.21 | $14,915,000,000.00 | Strong Buy | 12 | N/A |
#3 | CCJ | Canada | $88.21 | $2,487,042,049.00 | Buy | 6 | N/A |
#4 | MARA | United States | $11.67 | $919,173,000.00 | Buy | 14 | N/A |
#5 | DT | United States | $44.54 | $1,852,532,000.00 | Buy | 22 | 2019 |
#6 | TME | China | $18.40 | $4,455,416,345.00 | Strong Buy | 5 | 2018 |
#7 | ADEA | United States | $12.30 | $379,912,000.00 | Strong Buy | 4 | N/A |
#8 | SCHW | United States | $92.57 | $22,914,000,000.00 | Buy | 17 | 1987 |
#9 | BOX | United States | $29.58 | $1,125,704,000.00 | Buy | 10 | 2015 |
#10 | IRM | United States | $86.19 | $6,639,849,000.00 | Strong Buy | 6 | 1996 |
#11 | UTI | United States | $22.94 | $835,616,000.00 | Strong Buy | 5 | 2003 |
#12 | WIX | Israel | $96.39 | $1,929,230,000.00 | Strong Buy | 21 | 2013 |
#13 | DLO | Uruguay | $13.44 | $960,191,000.00 | Buy | 9 | 2021 |
#14 | RMBS | United States | $94.79 | $678,488,000.00 | Strong Buy | 7 | 1997 |
#15 | CGNX | United States | $38.18 | $971,705,000.00 | Buy | 12 | 1989 |
#16 | LMAT | United States | $83.29 | $240,866,000.00 | Buy | 6 | 2006 |
#17 | GIL | Canada | $55.46 | $3,362,263,000.00 | Buy | 7 | 1998 |
#18 | DINO | United States | $53.07 | $26,905,000,000.00 | Buy | 12 | N/A |
#19 | TBBK | United States | $64.11 | $523,163,000.00 | Buy | 4 | 2004 |
#20 | LRN | United States | $63.64 | $2,475,117,000.00 | Buy | 4 | 2007 |
#21 | SIMO | Hong Kong | $88.41 | $798,326,000.00 | Strong Buy | 8 | 2005 |
#22 | APAM | United States | $41.42 | $1,158,234,000.00 | Buy | 4 | 2013 |
#23 | FLEX | United States | $58.49 | $26,333,000,000.00 | Strong Buy | 9 | 1994 |
#24 | VSAT | United States | $34.26 | $4,582,796,000.00 | Buy | 7 | 1996 |
#25 | OPRX | United States | $15.24 | $109,506,000.00 | Buy | 6 | N/A |
#26 | MIAX | United States | $45.90 | $1,318,535,000.00 | Buy | 6 | 2025 |
#27 | SKYT | United States | $15.08 | $346,587,000.00 | Strong Buy | 5 | 2021 |
#28 | CEVA | United States | $21.51 | $107,530,000.00 | Strong Buy | 4 | 2000 |
#29 | IREN | Australia | $47.88 | $688,554,000.00 | Buy | 11 | 2021 |
#30 | MCHP | United States | $53.34 | $4,212,399,999.00 | Buy | 21 | 1993 |
#31 | ZLAB | China | $20.34 | $441,629,000.00 | Buy | 6 | 2017 |
#32 | ACLX | United States | $72.40 | $35,898,000.00 | Strong Buy | 9 | 2022 |
#33 | NGNE | United States | $21.19 | $0.00 | Strong Buy | 6 | N/A |
#34 | VYX | United States | $10.14 | $2,653,000,000.00 | Buy | 6 | N/A |
#35 | UUUU | United States | $14.36 | $78,742,000.00 | Strong Buy | 5 | N/A |
#36 | CMPO | United States | $19.85 | $160,683,000.00 | Strong Buy | 6 | N/A |
#37 | ASTS | United States | $56.29 | $18,531,000.00 | Buy | 9 | N/A |
#38 | ORIC | United States | $11.83 | $0.00 | Strong Buy | 11 | 2020 |
#39 | SOUN | United States | $12.01 | $148,404,000.00 | Buy | 7 | N/A |
#40 | OKTA | United States | $80.39 | $2,763,000,000.00 | Buy | 39 | 2017 |
#41 | ROKU | United States | $96.51 | $4,543,395,000.00 | Buy | 20 | 2017 |
#42 | DD | United States | $39.70 | $12,843,000,000.00 | Buy | 12 | N/A |
#43 | VRNS | United States | $33.06 | $608,677,000.00 | Strong Buy | 19 | 2014 |
#44 | IPGP | United States | $79.70 | $963,643,000.00 | Strong Buy | 6 | 2006 |
#45 | RKLB | United States | $42.06 | $554,535,000.00 | Buy | 14 | N/A |
#46 | NTNX | United States | $47.71 | $2,617,547,000.00 | Buy | 16 | 2016 |
#47 | RGTI | United States | $25.65 | $7,494,000.00 | Strong Buy | 5 | N/A |
#48 | AMPX | United States | $11.26 | $58,408,000.00 | Strong Buy | 7 | N/A |
#49 | AMBA | United States | $73.80 | $373,850,000.00 | Strong Buy | 10 | N/A |
#50 | PRGO | Ireland | $13.37 | $4,281,800,000.00 | Buy | 4 | 1991 |
The FinQuota filters have identified what they believe to be the "Best Under $100 Stocks to Buy on November 30, 2025" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.